Navigation Links
Signalife Sees Accretive Purchase and Financial Commitments
Date:3/17/2008

LOS ANGELES, March 17 /PRNewswire-FirstCall/ -- Signalife, Inc. (Amex: SGN - News) announced earlier today that it has received several formal purchase and financial commitments with respect to acquisitions of the Company's technology licenses, devices and services. These commitments have come internationally, including in Japan, other parts of Asia and Europe, as well as domestically.

Dr. Harmison, the Company's President and CEO, stated: "I anticipate closing these transactions in the upcoming two to four weeks, which comprise significant business for the Company. With the experiential base developed during my tenure regarding the ECG data generated from the usage of our technologies -- not only by health care providers but also through numerous Athletes for Life-sponsored mobile health care screenings -- there are now numerous additional revenue streams that have naturally become available to the Company. Indeed, physicians have provided me with a variety of data and information following very successful screenings this past weekend on the Athletes for Life Mobile Health Center in Temecula, California. With this kind of data garnered from real patients in the field, the foundation for the expansion of our life-saving devices becomes stronger every day."

The Company did not state the exact amount of business contemplated by these developments, and it cautioned that there is no certainty that any of the transactions will close as contemplated -- or at all.

About Signalife

Signalife, Inc. is a life sciences company focused on the monitoring, detection and prevention of disease through continuous biomedical signal monitoring. Signalife uses its patented signal technology to design and develop medical devices, therapies and/or technologies that simplify and reduce the costs of cardiovascular disease.

Signalife is publicly traded on the American Stock Exchange under the symbol SGN. The website for the company is

SOURCE Signalife, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Signalife Wins Second Frost & Sullivan Technology Award
2. Signalife & Athletes Foundation Dispatch Mobile Health Center to Super Bowl
3. AMEX Notifies Signalife that It Will Need to Comply with Minimum Stockholders Equity Requirement
4. Signalife Presence at XIII World Congress on Cardiac Pacing and Electrophysiology
5. U.S. Patent 7,299,083 Awarded to Signalife
6. Signalife Receives FDA Clearance for OTC Non-Prescription Event Recorder Device
7. Signalife Continues to Procure Purchase Orders, Revenues
8. NFL Hall of Fame Legend Fred Biletnikoff Joins AFL/Signalife Cardiovascular Protection Team
9. Signalife Receives Another $3.3 Million Sales Orders
10. Signalife Achieves $1.98 Million Sales Orders Thus Far
11. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)...re-USNewswire/ -- The Michael J. Fox Foundation fo... million in total awards to six research teams wor...apies for Parkinson,s disease. The funding was awa... for Parkinson,s Disease program, made possible b...), a neuroscience-based biotechnology company. ,...
(Date:11/30/2009)... -- Dr. Jessica Torrente, Assistant Professor of R...enter in Washington, D.C., demonstrated the integr...GI) in clinical practice as an adjunct imaging mod...the annual meeting of the Radiological Society of ...hibit was to demonstrate how BSGI is used in the c...
(Date:11/30/2009)...in providing smart and efficient software to the p...eg;, evolutionizing work-from-home histopathology ...software used by 8 of the Top 10 Pharmaceutical Co...de’ basis. , Mount ... announced another evolution in the histopathology...
(Date:11/30/2009)...r 30 ApaTech, the rapidly growing,... growing,Biotech/Pharmaceutical/Medical Technology... Fast 500 for EMEA (Europe, Middle East and Africa...mpanies, five-year revenue growth,for which ApaTe... This,achievement places ApaTech 9th overall in th...
Breaking Biology Technology:The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3Breast-Specific Gamma Imaging In Clinical Practice as an Adjunct Imaging Modality for Diagnosis of Breast Cancer 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 3ApaTech is Europe's Fastest Growing Lifescience Company 2ApaTech is Europe's Fastest Growing Lifescience Company 3ApaTech is Europe's Fastest Growing Lifescience Company 4
... (Nasdaq: INSM ), a developer of follow-on biolo... that on Monday, March 23, 2009, NASDAQ issued a n...s requiring a minimum $1 closing bid price and tho...cly held shares (MVPHS). The suspension will rema...e original rules will be reinstated on Monday, Jul...
...all/ - Spectral Diagnostics Inc. (TSX:SDI), a comp...s, today announced that the 29th International Sym... Brussels, Belgium from March 24-27, 2009 will fea...e of Endotoxin", that will include presentations f...esentations will include topics such as defining t...
...all/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX...on of patient enrolment in its U.K. clinical trial...s administration of REOLYSIN(R) in combination wit...d cancers including breast, and head and neck. The... The Royal Marsden NHS Foundation Trust and The In...
Other Biology Technology:Insmed Announces That NASDAQ Further Extends Temporary Suspension of Minimum Bid Closing Price Rule 2Spectral announces presentations at the 29TH International Symposium on Intensive Care and Emergency Medicine focusing on the role of endotoxin 2Oncolytics Biotech(R) Inc. Completes Enrolment in Combination REOLYSIN(R)/Gemcitabine Trial 2Oncolytics Biotech(R) Inc. Completes Enrolment in Combination REOLYSIN(R)/Gemcitabine Trial 3
(Date:11/30/2009)... you ever thought the stress of seeing your extend...bad news: a new research report in the December 20...y ( http://www.jleukbio.org ) shows that you migh... same study might lead to entirely new treatments ...hritis, and eczema under control. That,s because r...
(Date:11/26/2009)...ized for their impressive antlers, red deer have b... But a deer,s antlers are much more than decorativ...er when duelling. John Currey, from The University... properties of bone for over half a century and ha...f antler through a long-standing collaboration wit...
(Date:11/26/2009)...SA (methicillin-resistant Staphylococcus Aureus )...hilation as low-temperature plasma prototype devic...and unfailing bactericidal cocktails. , Two prot...nt disinfection of healthy skin (e.g. hands and fe...can pose a lethal threat; and another to shoot bac...
Breaking Biology News(10 mins):Seeing family for the holidays? Scientists discover how the stress might kill you 2Tough yet stiff deer antler is materials scientist's dream 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Existing Drug May Lead to ALS Treatment 59797 1Existing Drug May Lead to ALS Treatment 59797 2Detailed Results from RV 144 HIV Vaccine Trial Published Today in The New England Journal of Medicine and Presented at the AIDS Vaccine 2009 Conferenc 59795 1Detailed Results from RV 144 HIV Vaccine Trial Published Today in The New England Journal of Medicine and Presented at the AIDS Vaccine 2009 Conferenc 59795 2Detailed Results from RV 144 HIV Vaccine Trial Published Today in The New England Journal of Medicine and Presented at the AIDS Vaccine 2009 Conferenc 59795 3Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 1Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 2Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 3Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 4Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 5Cardiac Science Expands into Vital Signs Market with Exclusive OMRON Healthcare Agreement 5585 6
...be looking at you, but are they really paying atte...ttention, without moving their eyes" Dr. Brian Co...versity of Western Ontario in London, Canada has f... His research Neuromuscular consequences of refle...ine Publication of "Nature Neuroscience". , Our ...
...als from a key molecular receptor that normally sw...ad becomes too intense in the presence of stress a...is (NEC), a leading cause of death in premature ne...ciety for Cell Biology 47th annual meeting. , Dav...ens Hospital of Pittsburgh report that neonatal mi...
... and mineralogy are scientific fields that have be...ge and technologies. The boundary of water and roc...w field of nanoparticle science. , Scientists are... 100 nanometers, influence natural and engineered ...ar materials of a larger size. Nanoparticles are i...
Other Biology News:Leading cause of death in 'preemies' might be controlled by resetting a molecular switch 2Between water and rock -- a new science 2Between water and rock -- a new science 3Between water and rock -- a new science 4Between water and rock -- a new science 5
Bromophenol Blue from Santa Cruz Biotechnology, Inc.
Feature Extraction Software; 1-year license for Commercial from Agilent Technologies
...Radiochemical Purity is >95%NEN Radiolabeled Ligan...led by the continual availability of new radiolabe...ries. PerkinElmer offers a wide range of products ...ery, including over 400 state-of-the-art radioliga...
...The ICS-1500 system provides excellent performance...ng, electrolytic suppression, and column heater al...fers outstanding sensitivity and stability. The va...for trace-level work. Operate in manual or automat...
Biology Products: